What's in Manipal Acunova Ltd.'s pipeline?

Manipal Acunova Ltd. has 1 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Manipal Acunova Ltd.'s portfolio?

Top competitors by shared drug class: Ain Shams Maternity Hospital, Gary A Levy, O. Ont. MD. FRCP AGAF, Gwo Xi Stem Cell Applied Technology Co., Ltd., Mesoblast, Inc., Nature Cell Co. Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/manipal-acunova-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Manipal Acunova Ltd. — Portfolio Competitive Intelligence Brief

Manipal Acunova Ltd. pipeline: 0 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ain Shams Maternity Hospital · 1 shared drug class
Gary A Levy, O. Ont. MD. FRCP AGAF · 1 shared drug class
Gwo Xi Stem Cell Applied Technology Co., Ltd. · 1 shared drug class
Mesoblast, Inc. · 1 shared drug class
Nature Cell Co. Ltd. · 1 shared drug class
Tigenix S.A.U. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Manipal Acunova Ltd.:

Cite this brief

Drug Landscape (2026). Manipal Acunova Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/manipal-acunova-ltd. Accessed 2026-05-16.